ReviewFrontiers in oral health2025
Role of optical imaging in oral cancer and oral potentially malignant disorders: implications for oral submucous fibrosis.
Review in Frontiers in oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral submucous fibrosis (OSF) is a chronic, potentially malignant disorder characterized by progressive stromal fibrosis and epithelial atrophy, leading to functional loss and an increased risk of malignant transformation. Areca nut consumption remains the principal etiological factor in South and Southeast Asia. Despite its distinct clinicopathological features, OSF assessment relies largely on clinical examination and invasive biopsy, underscoring the need for non-invasive approaches capable of interrogating tissue structure and composition. Optical imaging (OI) technologies, including confocal-based imaging, optical coherence tomography (OCT), narrow-band imaging (NBI), and Raman spectroscopy (RS), have been widely investigated in oral potentially malignant disorders (OPMDs) and oral squamous cell carcinoma (OSCC). However, the applicability of OI to OSF remains undefined. The aims of this narrative review are to: 1) critically synthesize current OI evidence in oral mucosal disease, and 2) evaluates the biological plausibility and technical limitation of applying these modalities to OSF from a pathobiology point of view. Highlighted in this review are the cellular and extracellular matrix alterations that may generate measurable optical signals and the paucity of OSF-specific validation studies, in addition to discussing constraints related to imaging penetration depth and disease grading, and outlining future research directions, including extracellular-matrix-focus optical biomarkers and artificial intelligence-assisted analysis. Collectively, this work positions OI in OSF as a hypothesis-generating and exploratory domain requiring rigorous, pathology-correlated investigation before clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.